期刊文献+

超敏C反应蛋白在AECOPD中的临床价值 被引量:8

Clinical value of high-sensitivity C-reactive protein in patients with AECOPD
下载PDF
导出
摘要 目的探讨超敏C反应蛋白(HSCRP)在AECOPD患者中的临床价值。方法检测30例稳定期COPD患者以及30例AECOPD患者治疗前后的血清HSCRP、白细胞计数(WBC)、中性粒细胞百分率(N%),比较其在稳定期COPD患者与AE-COPD患者治疗前后之间的差异。结果 AECOPD患者治疗前HSCRP水平显著高于治疗后及稳定期COPD患者(P<0.01),治疗前WBC、N%水平高于与治疗后(P<0.05),治疗后HSCRP、WBC、N%水平与稳定期COPD患者相比无显著性差异(P>0.05)。结论 HSCRP是反应机体炎症反应的敏感指标,对AECOPD的及早诊断及疗效判定具有重要临床价值。 Objective To discuss the clinical value of high-sensitivity C-reactive protein (hs-CRP) in patients with AECOPD. Methods 30 patients with stable COPD and 30 patients with AECOPD were selected in the this study, and their hs-CRP, white blood cell count (WBC) , neutrophil percentage ( N% ) in serum were tested before and after the treatment. The differences were compared be- tween the patients with stable COPD and AECOPD. Results The level of hs-CRP was obviously higher in the AECOPD group before the treatment than that after the treatment and the stable COPD group (P 〈0.01 ). There was no obvious difference of WBC and N% before and after the treatment (P 〉0. 05). After the treatment, there was no significant difference of the levels of hsCRP, WBC and N% be- tween the AECOPD group and the stable COPD group ( P 〉 0.05 ). Conclusion As a sensitive indicator of physical inflammatory re- sponse, hs-CRP has an important clinical value in the early diagnosis of patients with AECOPD and therapeutic efficacy.
作者 李洁 范铁兵
出处 《临床肺科杂志》 2013年第6期997-998,共2页 Journal of Clinical Pulmonary Medicine
关键词 超敏C反应蛋白 慢性阻塞性肺疾病 急性加重期 high-sensitivity C-reactive protein chronic obstructive pulmonary disease acute phase
  • 相关文献

参考文献5

二级参考文献18

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 3熊曙光,陈余思.C反应蛋白在慢性阻塞性肺疾病急性加重期的应用评价[J].临床肺科杂志,2007,12(6):608-610. 被引量:33
  • 4GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 5Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 6Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 7冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 8温加登,史密斯,贝内特.西氏内科学[M].第19版,西安:世界图书出版西安公司,1995.97-98.
  • 9Roberts WL, Sedrick R, Mouhon L, et al. Evaluation of four auto- mated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications[ J]. Clin Chem. 2000 ;46 (4) :461 -8.
  • 10Aziz N,Fahey JL,Detels R,et al. Analytical performance of ahighly sensitive C-reactive pretein-basedimmunoassay andthe effects of La- boratory variables on Levels of protein in blood[ J]. Clin Diagn Lab Immunol,2003,10 (4) :652 - 657.

共引文献8329

同被引文献54

  • 1蔡柏蔷.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(草案)[J].中华哮喘杂志(电子版),2013,7(1):1-13. 被引量:193
  • 2Tie-Gang Jia,Jian-Qing Zhao,Jian-Hua Liu.Serum inflammatory factor and cytokines in AECOPD[J].Asian Pacific Journal of Tropical Medicine,2014,7(12):1005-1008. 被引量:21
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 4钟南山,刘又宁.呼吸病学[M].第2版,北京:人民卫生出版社,2012:357-359.
  • 5Egorova EN, Kuz'mina MI, Mazur VV, et al. Trends in systemic inflammatory factors and aminoterminal brain natriuretic propeptide in the treatment of chronic heart failure [ J ]. Kalinkin MN, Mazur ES ,Ter Arkh ,2011,83 ( 1 ) :56 - 9.
  • 6Speranza L, Franceschelli S, Ricciani G, et al. BNP and iNOS in decompensated chronic heart failure :a linear correlation [ J ]. Front Biosci (Elite Ed) ,2012,1 (4) :1255 -62.
  • 7Zhong N,Wang C,YaoW,et al.Prevalence of chronic obstructive pulmonary disease in China:a large,population-based survey[J].Am J Respir Crit Care Med,2007,176(8):753-760.
  • 8Tillet W S,Francis T.Serological reactions in pneumonia with a non-protein somatic fraction of the pneumococcus[J].J Exp Med,1930,52(5):561-564.
  • 9Kriti Upadhyay,Arvind Uniyal,Randeep Guleria,et al.Serum Prealbumin Is a Useful Marker of Inflammation and Monitoring Tool in Patients With AECOPD[J].Chest,2013,144(4_MeetingAbstracts):708A.
  • 10Zhong N,Wang C,Yao W,et al.Prevalence of chronic obstructivepulmonary disease in China:a large,populationbased survey.American Journal of Respiratory and Critical Care Medicine,2007,5(21):122-125.

引证文献8

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部